ABECMA

Registered
Combined Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

CC

Owner Name

Type: Organization / Corporation

Address

86 Morris Avenue
Summit, NJ 07901

Critical Dates

First Use Date

Mar 26, 2021

Filing Date

Aug 14, 2019

Registration Date

Aug 16, 2022

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for use in the treatment of multiple myeloma, cancer, diseases in the fields of oncology; pharmaceutical preparations, namely, cytokine inhibitory drugs

Mark Elements

Text Mark
ABECMA
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description

The mark consists of "ABECMA" in red font with a hummingbird design to the left and above the "A" with its head in light blue and its wings fluttering quickly with the colors red, light blue, green and light and dark purple.

Color Details

The color(s) red, green, light blue, and light and dark purple is/are claimed as a feature of the mark.

Design Search Codes
03.15.19
Birds in flight or with outspread wings
03.15.24
Stylized birds
03.15.25
Blackbirds
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Mar 26, 2021

Filing Date

Aug 14, 2019

Publication Date

Oct 22, 2019

Registration Date

Aug 16, 2022

USPTO Records

Title
Date
Category
Source
Pages
Format
Actions
Notice of Registration-Notice
NOTRG(8 KB)
Aug 16, 2022
Outgoing
CMS
1
PDF
Registration Certificate
ORC(336 KB)
Aug 16, 2022
Outgoing
CMS
1
PDF
TRAM Snapshot of App at Pub for Oppostn (Part 1)
PST
Jul 12, 2022
TRAM Snapshot
TICRS
2
XML
TRAM Snapshot of App at Pub for Oppostn (Part 2)
PST
Jul 12, 2022
TRAM Snapshot
TICRS
2
JPEG
Notice of Acceptance of Statement of Use
ASU
Jul 12, 2022
Outgoing
TICRS
1
XML
ITU Unit Action (Part 1)
IUA
Jun 3, 2022
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Jun 3, 2022
TRAM Snapshot
TICRS
2
JPEG
Statement of Use (Part 1)
SOU
May 26, 2022
Incoming
TICRS
3
XML
Statement of Use (Part 2)
SOU
May 26, 2022
Incoming
TICRS
3
JPEG
Statement of Use (Part 3)
SOU
May 26, 2022
Incoming
TICRS
3
TIFF
Specimen
SPE
May 26, 2022
Specimens
TICRS
1
JPEG
ITU Unit Action (Part 1)
IUA
Dec 14, 2021
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Dec 14, 2021
TRAM Snapshot
TICRS
2
JPEG
ITU Extension Approval
AER
Dec 14, 2021
Outgoing
TICRS
1
XML
Extension of Time to File SOU
ESU
Dec 10, 2021
Incoming
TICRS
1
XML
ITU Unit Action (Part 1)
IUA
Jun 18, 2021
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Jun 18, 2021
TRAM Snapshot
TICRS
2
JPEG
ITU Extension Approval
AER
Jun 18, 2021
Outgoing
TICRS
1
XML
Extension of Time to File SOU
ESU
Jun 16, 2021
Incoming
TICRS
1
XML
Amendment and Mail Process Complete (Part 1)
AMC
Jun 15, 2021
TRAM Snapshot
TICRS
2
XML
Amendment and Mail Process Complete (Part 2)
AMC
Jun 15, 2021
TRAM Snapshot
TICRS
2
JPEG
Post Publication Amendment
PPA
Jun 9, 2021
Incoming
TICRS
1
XML
ITU Unit Action (Part 1)
IUA
Dec 19, 2020
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Dec 19, 2020
TRAM Snapshot
TICRS
2
JPEG
ITU Extension Approval
AER
Dec 19, 2020
Outgoing
TICRS
1
XML

AI AssessmentCached Mar 12, 2026, 06:13 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The mark ABECMA consists of the word in red font with a stylized hummingbird design to the left and above the "A", featuring colors red, green, light blue, and light and dark purple, and covers pharmaceutical preparations for the treatment of multiple myeloma, cancer, oncology diseases, and cytokine inhibitory drugs in Class 005. It is owned by Celgene Corporation, a Delaware corporation based in Summit, New Jersey. The mark is registered on the Principal Register since August 16, 2022, with first use in commerce on March 26, 2021, and no notable issues or legal proceedings are present.

Recent Activity

Filed on August 14, 2019, the application was published for opposition on October 22, 2019, and issued a Notice of Allowance on December 17, 2019. After several extensions, a Statement of Use was accepted on July 10, 2022, leading to registration on August 16, 2022.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 06:13 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.